• A multivariate retrospective analysis of high-grade gliomas: Survival and prognostic factors
• A novel method for cell deconvolution using DNA methylation in PCA space
• A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential
• A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
• Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells
• ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages
• Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth
• Association between dichotomized VASARI feature and overall survival in glioblastoma patients: a single-institution propensity score matching analysis
• Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds
• Beyond hand-crafted features for pretherapeutic molecular status identification of pediatric low-grade gliomas
• CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
• CD58 defines regulatory macrophages within the tumor microenvironment
• Changes in perfusion and permeability in glioblastoma model induced by the anti-angiogenic agents cediranib and thalidomide
• Clinical characterization and long-term postoperative outcomes of retinoblastoma patients receiving enucleation and primary orbital implantation in early infancy: an observational study
• Clinical significance of sarcopenia in children with neuroblastic tumors
• Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas
• Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model
• Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance
• Comparing nnU-Net and deepflash2 for Histopathological Tumor Segmentation
• Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma
• Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma
• Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway
• Disseminated ependymal dysembryoplastic neuroepithelial tumor: a case report and literature review
• Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics
• Effect of Ferulic Acid Loaded in Nanoparticle on Tissue Transglutaminase Expression Levels in Human Glioblastoma Cell Line
• EIF4A3-induced hsa_circ_0078136 inhibits the tumorigenesis of retinoblastoma via IL-17 signaling pathway
• Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy
• Establishment of an Engineered Bacterial Membrane Biomimetic Nanodrug Delivery System and Its Role in the Treatment of Glioma
• Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy
• Exploring the effects of three-finger toxins from Naja ashei venom on neuronal and immunological cancer cell membranes
• First independent validation of the proton-boron capture therapy concept
• Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression
• Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review)
• GPR65 contributes to constructing immunosuppressive microenvironment in glioma
• GSTO2 ameliorates human neuroblastoma cell apoptosis, inflammation, ferroptosis, and oxidative stress by upregulating GPX4 expression in intracerebral hemorrhage
• How I do it? Resection of left ventricular central neurocytoma via trans-sulcal approach
• Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors
• Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
• Inhibition of AIM2 expression enhance treatment effect of osimertinib in treatment of glioma
• Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models
• Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma
• Integrative single-cell and bulk transcriptome analyses identify a distinct pro-tumor macrophage signature that has a major prognostic impact on glioblastomas
• Interleukin 4 and cancer resistance in glioblastoma multiforme
• Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
• Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing
• Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis
• Kinetic Trajectories of Glucose Uptake in Single Cancer Cells Reveal a Drug-Induced Cell-State Change Within Hours of Drug Treatment
• Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells
• Leading medulloblastoma to a differentiation end
• Length of phone use and glioma risk: a Mendelian randomization study
• Letter to the Editor: "The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma"
• Living with glioblastoma - the need for integrated support based on experiences of chaos, loss of autonomy, and isolation in both patients and their relatives
• Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress
• Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers
• Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin
• Molecular and Pathological Features of Paediatric High-Grade Gliomas
• Molecular imaging with 68Ga-PSMA PET/CT in high grade glioma: A biomarker for tumour neo-angiogenesis
• MR-guided laser interstitial thermal therapy in the treatment of brain tumors and epilepsy
• Multinodular and vacuolating neuronal tumor in the thalamus: case report and systematic review of literature
• Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin
• Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
• Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging
• NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation
• Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma
• Physical therapy enhances physical and functional abilities in a female patient with gliomatosis cerebri
• Potential of GSPT1 as a novel target for glioblastoma therapy
• Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma
• Prenyl Pterocarpans from Algerian <em>Bituminaria bituminosa</em> and Their Effects on Neuroblastoma
• PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma
• Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy
• Real-time estimation of the optimal coil placement in transcranial magnetic stimulation using multi-task deep learning
• Reproducibility of Radiomic Features in Glial Brain Tumors
• Response to PARP Inhibition in <em>BARD1</em>-Mutated Refractory Neuroblastoma
• Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway
• Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis
• Rosettes and pseudorosettes in veterinary neuropathology
• S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages
• SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4
• Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning
• Solitary isolated disseminations of glioblastoma to sellar and suprasellar regions: two case reports
• Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies
• Sphingosine 1-Phosphate Stimulates ER to Golgi Ceramide Traffic to Promote Survival in T98G Glioma Cells
• Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy
• Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience
• T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
• The complex molecular epileptogenesis landscape of glioblastoma
• The effects of dabrafenib and/or trametinib treatment in Braf V600-mutant glioma: a systematic review and meta-analysis
• The importance of the circRNA/Wnt axis in gliomas: Biological functions and clinical opportunities
• The role of NPC2 gene in glioma was investigated based on bioinformatics analysis
• The role of postoperative blood pressure management in early postoperative hemorrhage in awake craniotomy glioma patients
• Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling
• Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells
• TiO₂-ZnPc nanoparticles functionalized with folic acid as a target photosensitizer for photodynamic therapy against glioblastoma cells
• Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma
• Unusual delayed postradiation vasculopathy mimicking tumour in an early adolescent with a remote history of metastatic medulloblastoma
• Urinary D-asparagine level is decreased by the presence of glioblastoma
• Utilizing machine learning to tailor radiotherapy and chemoradiotherapy for low-grade glioma patients
• VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells
• Virtual reality: a game-changer in the diagnosis and surgical planning of astrocytoma grade III: a case report
• When playing the NK cell therapy card in glioblastoma, you can't beat interleukin-21